Status:

UNKNOWN

A Novel Method for Retrograde Intrarenal Surgery (RIRS)

Lead Sponsor:

Ankara Training and Research Hospital

Conditions:

Kidney Stone

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this prospective randomised controlled study, investigators aims to evaluate the effect of 80 mg gentamicin added to 3 liters of irrigation fluid on stone free rate, intraoperative and postoperativ...

Detailed Description

Current advances in endoscopic technology for the upper urinary tract have expanded the diagnosis and treatment options for kidney stones. Retrograde intrarenal surgery (RIRS), defined as the use of e...

Eligibility Criteria

Inclusion

  • \<2 cm. kidney stones

Exclusion

  • Ureteral stricture
  • Active urinary tract infection
  • Coagulopathies

Key Trial Info

Start Date :

February 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2022

Estimated Enrollment :

76 Patients enrolled

Trial Details

Trial ID

NCT05202158

Start Date

February 15 2022

End Date

September 1 2022

Last Update

July 7 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ankara Training and Research Hospital

Ankara, Altindag, Turkey (Türkiye), 06230

A Novel Method for Retrograde Intrarenal Surgery (RIRS) | DecenTrialz